Literature DB >> 15036618

4-Hydroxynonenal oxidatively modifies histones: implications for Alzheimer's disease.

Jennifer Drake1, Robin Petroze, Alessandra Castegna, Qunxing Ding, Jeffrey N Keller, William R Markesbery, Mark A Lovell, D Allan Butterfield.   

Abstract

There is increasing evidence of DNA oxidation and altered DNA repair mechanisms in Alzheimer's disease (AD) brain. Histones, which interact with DNA, conceivably could provide a protective shield for DNA against oxidative stress. However, because of their abundant lysine residues, histones may be a target for 4-hydroxynonenal (HNE) modification. In this study, we have shown that HNE binds to histones and that this binding affects the conformation of the histone, measured by electron paramagnetic resonance in conjunction with a protein-specific spin label. The covalent modification to the histone by HNE affects the ability of the histone to bind DNA. Interestingly, acetylated histones appear to be more susceptible to HNE modifications than control histones. Conceivably, altered DNA-histone interactions, subsequent to oxidative modification of histones by the lipid peroxidation product HNE, may contribute to the vulnerability of DNA to oxidation in AD brain.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15036618     DOI: 10.1016/j.neulet.2003.11.047

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  20 in total

1.  Increased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer disease.

Authors:  M A Bradley; W R Markesbery; M A Lovell
Journal:  Free Radic Biol Med       Date:  2010-02-18       Impact factor: 7.376

Review 2.  Developmental origins of adult disease.

Authors:  Rebecca A Simmons
Journal:  Pediatr Clin North Am       Date:  2009-06       Impact factor: 3.278

3.  Transcriptional signatures mediated by acetylation overlap with early-stage Alzheimer's disease.

Authors:  J Vadnal; S Houston; S Bhatta; E Freeman; J McDonough
Journal:  Exp Brain Res       Date:  2012-07-19       Impact factor: 1.972

4.  Histone h3 glutathionylation in proliferating mammalian cells destabilizes nucleosomal structure.

Authors:  José Luis García-Giménez; Gloria Òlaso; Sandra B Hake; Clemens Bönisch; Sonja M Wiedemann; Jelena Markovic; Francisco Dasí; Amparo Gimeno; Carme Pérez-Quilis; Oscar Palacios; Mercè Capdevila; José Viña; Federico V Pallardó
Journal:  Antioxid Redox Signal       Date:  2013-05-21       Impact factor: 8.401

5.  Elevated 4-hydroxyhexenal in Alzheimer's disease (AD) progression.

Authors:  Melissa A Bradley; Shuling Xiong-Fister; William R Markesbery; Mark A Lovell
Journal:  Neurobiol Aging       Date:  2010-10-20       Impact factor: 4.673

6.  Peroxynitrite-induced nitrative and oxidative modifications alter tau filament formation.

Authors:  Laurel Vana; Nicholas M Kanaan; Kevin Hakala; Susan T Weintraub; Lester I Binder
Journal:  Biochemistry       Date:  2011-01-26       Impact factor: 3.162

Review 7.  The path to epigenetic treatment of memory disorders.

Authors:  Mikael A Mikaelsson; Courtney A Miller
Journal:  Neurobiol Learn Mem       Date:  2011-02-12       Impact factor: 2.877

Review 8.  Systems analysis of protein modification and cellular responses induced by electrophile stress.

Authors:  Aaron T Jacobs; Lawrence J Marnett
Journal:  Acc Chem Res       Date:  2010-05-18       Impact factor: 22.384

Review 9.  Epigenetic mechanisms in the development of type 2 diabetes.

Authors:  Sara E Pinney; Rebecca A Simmons
Journal:  Trends Endocrinol Metab       Date:  2009-10-26       Impact factor: 12.015

Review 10.  Role of metabolic programming in the pathogenesis of beta-cell failure in postnatal life.

Authors:  Rebecca A Simmons
Journal:  Rev Endocr Metab Disord       Date:  2007-06       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.